Personal Info
Specializing in allografts for 30 years, he was the first to introduce treated and viro-inactivated human tissues in France through Scient’X.
The market has adopted this alternative to autologous or cryopreserved grafts as an opportunity that will impose itself over the years.
As a co-founder of Scient’X and then Medical Dynamique, he also turned to promoting implants for spine surgery, notably introducing micromobility in lumbar osteosynthesis systems.
This innovative solution has won over the majority of surgeons. It is now adopted by the main players in the sector. He returned to allografts through Tutogen France and, since 2007, with the LBTB in Luxembourg, he aims to establish it as a European leader.
« I have always matured my initiatives in proximity to users who, better than anyone, assess their relevance to the benefit of the patient. »,
Luc A. ALBY says
